MicroRNAs in diabetic kidney disease
Diabetic kidney diseases is one of the diabetic microvascular complications. Type 1
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Diabetic kidney diseases is one of the diabetic microvascular complications. Type 1
MicroRNAs or miRNAs are small non-coding RNAs which are important regulators of various developmental and survival processes of the eukaryotic organisms. They regulate the expression of genes post-transcriptionally
microRNAs (miRNAs), short noncoding RNA sequences, regulate several biological processes as cell differentiation, proliferation and development, cell-to-cell communication, cell metabolism and apoptosis. miRNAs seem…
therapy. But the underlying molecular mechanisms remain largely unknown. Thus, a special focus on microRNA regulation was the goal of our study. In our previous study, we investigated the molecular ... CD25- CD127low T…
microRNA-200 family is a small molecule which can play a potential role in cancer diagnosis and treatment. The miR-200 family includes 5 members (miR-200a ... study of lin-4 in Caenorhabditis elegans identified a novel…
characteristics, comorbidities, and miRs expression level were estimated. Results: The expression levels of most microRNAs were statistically different between groups, with ... with 80% sensitivity and 95% specificity…
earlier stage and slow down its progression. Small non-coding RNAs, microRNAs (miRNAs), are modulators of gene expressions and play important roles in cellular processes. Recent studies implicate certain miRNAs
healing: inflammation (pro- inflammatory stage), proliferation and remodeling (regenerative stage). Non-coding RNAs, including microRNAs, maintain critical roles in regulating normal biological processes, such as wound…
patients with aggressive PTC and 18 patients with non-aggressive PTC were studied. The microRNAs expressions were evaluated using real-time PCR. Fold changes (FC) of the miRs in aggressive
light and gained researchers interest. Among the different subsets of these non-coding RNAs, microRNAs were identified as 18-25 nucleotides long and have been shown to play critical regulatory
MicroRNAs(miRNAs) are 19-25 nucleotide non-coding regulatory RNAs,that participate in a variety of developmental pathways. The deregulation of microRNAs has been reported in human cancers. Recent data
patient management. In recent times, the translational research paradigm has evolved to understand that microRNA (small, non-coding molecules, 19-25 nucleotides in length) are key modulators in oncogenesis. Monitoring
MicroRNA (miRNA) was at the start discovered in Caenorhabditis elegans by Victor Ambrose' laboratory in 1993 whereas learning the sequence lin-14. At constant time, port of entry Ravkun known
Breast cancer growth is the most widely recognized disease influencing females around
offer several possibilities for translational research and cancer patient stratification. Some examples based on microRNA expression in solid tumours will be discussed. MicroRNAs are pivotal regulators for RNA silencing…
For authors and organisers
Find the right journal for your paper and submit your manuscript.